美国物理治疗 USPH

Mr. Reading has served as our Chief Executive Officer and a director since 2004 and as the Chairman of the Board since May 2024. Mr. Reading joined the Company in 2003 and served as our Chief Operating Officer until his promotion. Mr. Reading currently serves as President of The Alliance for Physical Therapy Quality and Innovation (APTQI). APTQI is an industry organization that advocates for legislative and regulatory changes on behalf of the physical therapy community that furthers our mission of ensuring patient access to value driven physical therapy care. Prior to joining the Company, Mr. Reading served in various executive and management positions with HealthSouth Corporation, including his ultimate position as Senior Vice President of Operations, where he focused on operations, acquisitions and development in various service areas including outpatient rehabilitation, ambulatory surgery, diagnostic imaging and inpatient rehabilitation hospitals. Also, Mr. Reading is a physical therapist.

Eric J. Williams, was appointed as Chief Operating Officer - East effective July 1, 2021, and was promoted to President and Chief Operating Officer, effective as of May 21, 2024. From 2018 through April, 2021, Mr. Williams served as President and Chief Operating Officer for Omni Ophthalmic Management Consultants (OOMC), an ophthalmology management services organization. From 2010 until 2018, Mr. Williams served in the roles of Chief Operating Officer and then Chief Executive Officer of Drayer Physical Therapy Institute, LLC, an outpatient physical therapy provider with a network of over 150 clinics in 14 states. Prior to his role at Drayer, Mr. Williams served as Executive Vice President and Chief Operating officer at Care One, a provider of nursing home and long-term care services. From 2007 through 2009, Mr. Williams served as Executive Vice President of Operations for Physiotherapy Associates, Inc., a national outpatient physical therapy provider, and from 2003 through 2007 served as Chief Operating Officer of Benchmark Medical, Inc., also a national provider of outpatient physical therapy services which merged with Physiotherapy in 2007. Prior to that time, Mr. Williams held senior management positions at HealthSouth, at the time the largest national provider of outpatient physical therapy services in the United States.

Graham D. Reeve, was appointed as Chief Operating Officer - East effective March 5, 2018, and his title was subsequently changed to Chief Operating Officer - West effective as of July 1, 2021. From 2009 until the end of 2017, Mr. Reeve served as Chief Executive Officer of The Baptist Health System, an 1,800 bed six hospital system located in San Antonio, TX, which is a part of Tenet Healthcare. From 1995 to 2003, Mr. Reeve was employed by HealthSouth Corporation, a provider of outpatient surgery, diagnostic imaging, and rehabilitative healthcare services. From 1989 through 1995, Mr. Reeve was employed by Caremark Physical Therapy. Mr. Reeve is a physical therapist.

Richard S. Binstein, was appointed as Executive Vice President effective March 17, 2022, and continues to serve as the Company's General Counsel and Secretary, his positions since joining the Company in 2011. From 2001 through 2010, Mr. Binstein served as Vice President, General Counsel and Secretary for Physiotherapy Associates, Inc. (and its predecessor, Benchmark Medical, Inc.), a national provider of outpatient physical therapy services. From 1997 through 2000, Mr. Binstein served as Assistant General Counsel and then General Counsel of NovaCare, Inc., a national provider of rehabilitation services. Mr. Binstein practiced law in a law firm setting from 1986 through 1996.

Dr. Bernard A. Harris joined our Board in 2005 and has served as our Lead Independent Director since May 2024. Since 2018, Dr. Harris has served as Chief Executive Officer and Managing Partner of Vesalius Ventures, Inc. He currently serves on the boards of Raytheon Technologies (NYSE: RTX), Solventum (NYSE: SOLV) and MassMutual. He served as a trustee/director for Salient and Barings investment funds. He also served as a board member for the National Academies of Science, Engineering and Medicine - Board on Health Sciences Policy, and is currently on the boards of the Texas Medical Center, Astronaut Scholarship Foundation and the Harris Foundation, which he founded. Dr. Harris is a former NASA astronaut, has logged more than 438 hours and traveled over 7.2 million miles in space. He was a mission specialist on the space shuttle Columbia in 1993 and a payload commander on space shuttle Discovery in 1995. He completed a residency in internal medicine at the Mayo Clinic, a National Research Council Fellowship in endocrinology at the NASA Ames Research Center and trained as a flight surgeon at the United States Air Force School of Aerospace Medicine. He is a fellow of the American College of Physicians, and a member of the American Academy of Arts and Sciences.

Mr. Swanson joined our Board in 2007. Mr. Swanson was employed by STAR Physical Therapy, LP, a subsidiary of the Company, from 2007 through January 31, 2020. Mr. Swanson is founder of STAR Physical Therapy, LLC, and from 1997 to 2007, was its president and managing member. He is a certified athletic trainer and has been involved with sports medicine and physical therapy for over 25 years.

Ms. Gilmartin joined our Board in May 2018. Ms. Gilmartin is the former President and Chief Executive Officer of Caring Brands International and Interim HealthCare Inc., providers of home healthcare, skilled nursing, therapy and hospice care. Ms. Gilmartin's career spanned twenty-five years with Interim HealthCare Inc. where she served as President and Chief Executive Officer from September 2008 until her retirement in February 2017. Ms. Gilmartin served as a director of Caring Brands International and Interim Healthcare, Inc. from February 2017 through October 2021. Ms. Gilmartin served as a director of the Research Institute for Home Care (formerly the Alliance of Home Health Quality and Innovation), a non-profit, national consortium of home health care providers and organizations from 2009 through 2023. Since December 2022, Ms. Gilmartin has served as a director of Harmar Mobility LLC, a manufacturer of specialty mobility products and provider of a range of mobility and accessibility solutions. Ms. Gilmartin also serves as a director since December 2022 for 101 Mobility LLC, a national network of franchised providers that install and service mobility devices and solutions in client homes throughout the U.S. Ms. Gilmartin also serves as a director since November 2023, for Elevate Care International, a national network of franchised providers of non-medical personal care in the U.S., U.K., Canada and Ireland. Also, Ms. Gilmartin is a Registered Nurse.

Ms. Motsenbocker has served as a director of the Company since January 2022. She previously served as a Managing Director at JPMorgan Chase, a global financial services firm, until her retirement in 2021 following a 36-year career with the firm. During her tenure, she held roles of increasing responsibility advising companies on capital strategy, risk management, operational performance, and growth initiatives, including mergers and acquisitions. In her final role, she served for seven years as functional Chief Executive Officer of the Southwest region of the Commercial Bank. Ms. Motsenbocker currently serves as an independent director of CSW Industrials (NYSE: CSW), where she chairs the Audit Committee. She has also served since June 2025 as an Independent Trustee of Fortress Private Lending Fund, where she chairs the Nominating and Governance Committee and serves on the Audit Committee. She previously served as a director of Children's Health System of Texas from 2016 to 2022.

Mr. Mayrsohn joined our Board in May 2025. Mr. Mayrsohn is the Chief Executive Officer and an owner of Metro, which the Company acquired in October 2024. Mr. Mayrsohn has been employed by Metro since 2013 and was promoted to its Chief Executive Officer in 2016. Mr. Mayrsohn is a licensed physical therapist.

Myra Davis, 61, currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children's Hospital, a position she held since 2023. She has served in a variety of information services and information technology roles at Texas Children's Hospital since 2003, including Senior Vice President and Chief Information and Innovation Officer from 2019 to 2023 and Chief Information Officer from 2009 through 2019. In this role, Ms. Davis leads enterprise technology strategy, digital transformation, innovation, and information services for one of the nation's leading pediatric healthcare organizations. With more than two decades of CIO-level healthcare leadership, Ms. Davis is recognized for advancing secure, scalable technology solutions, cultivating high-performing teams, and positioning technology as a catalyst for innovation, operational excellence, and improved care delivery. Ms. Davis also serves on the Board of Directors of Werfen, a global medical diagnostics company, and on the Advisory Board of Healthcare Information Management Systems Society of America. Ms. Davis received a Bachelor of Science degree in Computer Information Processing from Loyola University, and a Master of Science degree in Software Design and Development from the University of St. Thomas.

Effective September 1, 2026, Nchacha Etta was appointed Executive Vice President and Chief Financial Officer of the Company. Mr. Etta, age 56, is the former Executive Vice President and Chief Financial Officer of Omnicell, Inc., a global healthcare and medical technology company, where he oversaw the company's global finance, information technology, investor relations strategies from 2023 to 2025. His breadth of finance and accounting experience stems from leading and working in global finance organizations across the healthcare, technology, consumer products and private equity sectors for more than 25 years. Prior to joining Omnicell, Mr. Etta served as Senior Vice President and Chief Financial Officer for Essilor of America,Inc., a subsidiary of EssilorLuxottica SA, from 2019 to 2022. Before that role, Mr.Etta served as the Worldwide Vice President and Chief Financial Officer of Johnson & Johnson Vision from 2015 to 2019, and for the previous nine years, he held various senior finance roles at The Coca-Cola Company. Earlier in his career, Mr. Etta worked at Microsoft Corporation, Eli Lilly & Company and The Carlyle Group. Mr. Etta received a Bachelor of Science degree in Accounting from George Mason University, and an MBA in Finance from Howard University. He has served as a member of the board of directors of KBR, Inc. since 2024 and is a member of its Audit Committee and Sustainability, Technology and Cybersecurity Committee.

Mr. Peter Francis Minan appointed to the board effective on 19 May 2026. Mr. Minan currently serves as a strategic financial consultant for Enviri Corporation (NYSE:NVRI), a multi-billion public company involved in environmental solutions, industrial waste processing, and rail industries manufacturing, as it prepares for its planned spinoff into New Enviri, at which time Mr. Minan will become its Senior Vice President and Chief Financial Officer. Mr. Minan was the Chief Financial Officer at Enviri Corporation for nine years until he retired in 2023. During 2012 and 2013, Mr. Minan served as Vice President Enterprise Risk and Internal Audit for CSC Corporation (now DXE Technology). Prior to CSC, Mr. Minan was a partner with KPMG LLC, a global organization of independent services firm providing audit, tax and advisory services to clients in the U.S. and around the world, until he retired in 2012. Over his 29 years with KPMG, he held roles of increasing responsibility, including National Managing Partner - U.S. Audit Practice, Partner in Charge-Washington DC/Baltimore Audit Business and Global Lead Audit Partner for a variety of Fortune 100 companies. Mr. Minan currently serves as an Adjunct Faculty member at Drexel University, where he has taught courses in Finance and Accounting.